Last reviewed · How we verify
NCT05680285
Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment
NA trial testing diode lazer in Pulpotomy in 90 participants. Completed in 30 May 2022.
30 May 2022
Quick facts
| Lead sponsor | Uşak University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 January 2021 |
| Primary completion | 30 May 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- diode lazer
- low level diode laser
Conditions studied
- Pulpotomy — all drugs for Pulpotomy →
Sponsor
Uşak University
Who can join
Adults 6 to 9, any sex, with Pulpotomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In our study, it was aimed to compare the long-term effectiveness of diode laser and low level laser therapy and primary tooth amputation treatments using calcium hydroxide (LLLT+CH) in primary second molars with deep dentinal caries. Ninety patients ( 42 Gırl, 48 Boy) aged 6-9 years with deep dentin caries in the mandibular second molar were included in the study. The patients were randomly selected according to the treatment to be applied and divided into two groups as the diode laser group (N=45) and the LLLT+CH group (N=45). The patients were called for control appointments at the 1st, 3rd, 6th and 12th months after the treatment, and both clinical and radiographic follow-ups were performed. Chi-square and Fisher's Exact tests were used to compare categorical variables according to groups in statistical analysis, and p\<0.05 was considered significant. When the study results at the end of 12 months were evaluated, the diode laser group had a clinical success rate of 95.6%, and a success rate of 93.3% radiologically; The LLLT+CH group had a success rate of 97.7% clinically and 90.9% radiologically. There was no statistically significant difference between the success rates of the groups (p\>0.05). According to the clinical and radiographic results of our study, it was determined that diode laser and LLLT+CH amputations showed similar success rates in primary second molars with deep dentin caries. It has been seen that both methods can be used safely in primary tooth amputations. It is thought that clinical and histological studies and studies examining the effectiveness of dental laser applications in primary tooth amputation treatment are needed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05680285
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulpotomy
Currently open trials in the same condition.
- NCT06685640 — Comparison of Clinical Success of Stainless Steel Crowns and Zirconia Crowns in Primary Molars · NA · recruiting
- NCT06288477 — Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Biocera · NA · recruiting
- NCT06640205 — Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars · NA · recruiting
- NCT04863222 — Clinical and Radiographic Success of MTA vs Biodentine · Phase 4 · recruiting
- NCT02298504 — Vital Pulp Treatment in Primary Teeth · Phase 4 · active not recruiting
Other Uşak University trials
Trials by the same sponsor.
- NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
- NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
- NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
- NCT07296367 — Physiotherapy and Disaster · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05680285 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uşak University
- Last refreshed: 11 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05680285.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing